Ekene Enemchukwu, MD, on underutilization of vaginal estrogen for GSM
April 15th 2025“Given the rates in epidemiologic studies and surveys showing that up to 70% of women are symptomatic, we were surprised to find that only 9% [filled] a prescription,” says Ekene Enemchukwu, MD, MPH, FACS, URPS.
How rBCG EAP could open up access for Anktiva in bladder cancer
April 11th 2025“I feel a lot of providers, with Antiva being available, have unfortunately reserved use of this great FDA-approved agent for BCG-unresponsive patients because of the supply issue with BCG," says Suzanne B. Merrill, MD, FACS.